Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vertex Pharmaceuticals Incorporated
Age
2–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Completed study drug treatment in the parent study (VX20-445-111 Part B, NCT04537793), or had study drug interruption(s) in the parent study, but did not permanently discontinue study drug, and completed study visits up to the last scheduled visit of the Treatment Period of the parent study
You may not be if
History of study drug intolerance in the parent study
History of poor compliance with ELX/TEZ/IVA and/or procedures in the parent study
Clareo Health | Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis (CF) Participants 2 Years and Older
